TNX-1300
Protein / enzyme therapeutic
Evidence outlook
Mid- and late-stage studies completed
This drug has completed mid- or late-stage studies. Where a sponsor has not posted registry results, topline data typically arrives via company announcements; see News.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
NCT01846481 NCT01846481 · Cocaine Intoxication Registry: NCT01846481 | 2 | Maximum plasma concentration (Cmax) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Time to Maximum Plasma Concentration (Tmax) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration (AUClast) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Elimination half-life (t1/2) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Area under the plasma concentration-time curve from time 0 to theoretical infinity (AUC0-inf) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Distribution half-life (t1/2α) of Cocaine (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Clearance (CL) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Volume of distribution (Vd) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Elimination rate constant (λz) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion); Mean residence time (MRT) of Cocaine, (-)Ecgonine methyl ester and RBP-8000 (21 samples from pre-dose of cocaine up to 731 minutes after start of cocaine infusion) 2013-06 | Results not posted; external-source review pending | not yet graded | link ↗ |
View 1 more trial
CATALYST NCT06045793 · Cocaine Intoxication Registry: NCT06045793 | 2 | Change from Baseline in Systolic BP at 60 minutes after dosing, comparing TNX-1300 to placebo with UC (60 minutes after IV administration) 2025-04-21 | Stopped early (terminated). Key figures are not recorded here. | not yet graded | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 2 (3)
What this study did
What this study did
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
No upcoming readouts on record for this asset.